Cargando…
Relationship between medical history and multiple sclerosis: A-case-control study
This project sought to explore the potential association between medical history and the development of multiple sclerosis (MS) by conducting a retrospective study. This population-based case-control study included 200 MS cases and 2 control groups of 200 patients and healthy individuals each. Data...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256330/ https://www.ncbi.nlm.nih.gov/pubmed/37335649 http://dx.doi.org/10.1097/MD.0000000000033906 |
_version_ | 1785057080771608576 |
---|---|
author | esfandiari, Fatemeh Ghazaiean, Mobin Darvishi-Khezri, Hadi Baghbanian, Seyed Mohammad |
author_facet | esfandiari, Fatemeh Ghazaiean, Mobin Darvishi-Khezri, Hadi Baghbanian, Seyed Mohammad |
author_sort | esfandiari, Fatemeh |
collection | PubMed |
description | This project sought to explore the potential association between medical history and the development of multiple sclerosis (MS) by conducting a retrospective study. This population-based case-control study included 200 MS cases and 2 control groups of 200 patients and healthy individuals each. Data was collected through face-to-face interviews, medical file reviews, and an electronic checklist. Multivariable analysis was used to calculate odds ratios and 95% confidence intervals to estimate the risk of each medical history on MS occurrences. Of 600 participants, 381 (63.5%) individuals were female. The mean age of the participants was 36.5 ± 11.9 years. The adjusted risks of MS were 4.40; 95% CI: 1.73 to 11.1 for measles and 4.75; 95% CI: 2.05 to 11 for amoxicillin consumption. The adjusted MS odds for autoimmune disease including 4.63; 95% CI: 0.35 to 60.6 for psoriasis and 7.15; 95% CI: 1.87 to 27.2 for myasthenia gravis. On the other hand, the calculated adjusted odds of MS occurrence were 0.14; 95% CI: 0.03 to 0.69 for seizure and 0.17; 95% CI: 0.02 to 1.49 for epilepsy. This study suggested that individuals with autoimmune diseases should be monitored more closely, as they may be at an increased risk of developing other autoimmune conditions, particularly MS. |
format | Online Article Text |
id | pubmed-10256330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-102563302023-06-10 Relationship between medical history and multiple sclerosis: A-case-control study esfandiari, Fatemeh Ghazaiean, Mobin Darvishi-Khezri, Hadi Baghbanian, Seyed Mohammad Medicine (Baltimore) 5300 This project sought to explore the potential association between medical history and the development of multiple sclerosis (MS) by conducting a retrospective study. This population-based case-control study included 200 MS cases and 2 control groups of 200 patients and healthy individuals each. Data was collected through face-to-face interviews, medical file reviews, and an electronic checklist. Multivariable analysis was used to calculate odds ratios and 95% confidence intervals to estimate the risk of each medical history on MS occurrences. Of 600 participants, 381 (63.5%) individuals were female. The mean age of the participants was 36.5 ± 11.9 years. The adjusted risks of MS were 4.40; 95% CI: 1.73 to 11.1 for measles and 4.75; 95% CI: 2.05 to 11 for amoxicillin consumption. The adjusted MS odds for autoimmune disease including 4.63; 95% CI: 0.35 to 60.6 for psoriasis and 7.15; 95% CI: 1.87 to 27.2 for myasthenia gravis. On the other hand, the calculated adjusted odds of MS occurrence were 0.14; 95% CI: 0.03 to 0.69 for seizure and 0.17; 95% CI: 0.02 to 1.49 for epilepsy. This study suggested that individuals with autoimmune diseases should be monitored more closely, as they may be at an increased risk of developing other autoimmune conditions, particularly MS. Lippincott Williams & Wilkins 2023-06-09 /pmc/articles/PMC10256330/ /pubmed/37335649 http://dx.doi.org/10.1097/MD.0000000000033906 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC) (https://creativecommons.org/licenses/by-nc/4.0/) , where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. |
spellingShingle | 5300 esfandiari, Fatemeh Ghazaiean, Mobin Darvishi-Khezri, Hadi Baghbanian, Seyed Mohammad Relationship between medical history and multiple sclerosis: A-case-control study |
title | Relationship between medical history and multiple sclerosis: A-case-control study |
title_full | Relationship between medical history and multiple sclerosis: A-case-control study |
title_fullStr | Relationship between medical history and multiple sclerosis: A-case-control study |
title_full_unstemmed | Relationship between medical history and multiple sclerosis: A-case-control study |
title_short | Relationship between medical history and multiple sclerosis: A-case-control study |
title_sort | relationship between medical history and multiple sclerosis: a-case-control study |
topic | 5300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256330/ https://www.ncbi.nlm.nih.gov/pubmed/37335649 http://dx.doi.org/10.1097/MD.0000000000033906 |
work_keys_str_mv | AT esfandiarifatemeh relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy AT ghazaieanmobin relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy AT darvishikhezrihadi relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy AT baghbanianseyedmohammad relationshipbetweenmedicalhistoryandmultiplesclerosisacasecontrolstudy |